{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:44:34Z","timestamp":1770482674275,"version":"3.49.0"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Respiratory syncytial virus (RSV) is an important cause of viral respiratory disease in children, and RSV bronchiolitis has been associated with the development of asthma in childhood. RSV spreads from the eye and nose to the human respiratory tract. Correlative studies of humans and direct infection studies of BALB\/c mice have established the eye as a significant pathway of entry of RSV to the lung. At the same time, RSV infection of the eye produces symptoms resembling allergic conjunctivitis. Cysteinyl leukotrienes (CysLTs) are known promoters of allergy and inflammation, and the first step in their biogenesis from arachidonic acid is catalyzed by 5-lipoxygenase (5-LO) in concert with the 5-LO-activating protein (FLAP). We have recently developed a novel compound, AM679, which is a topically applied and potent inhibitor of FLAP. Here we show with the BALB\/c mouse eye RSV infection model that AM679 markedly reduced the RSV-driven ocular pathology as well as the synthesis of CysLTs in the eye. In addition, AM679 decreased the production of the Th2 cell cytokine interleukin-4 but did not increase the viral load in the eye or the lung. These results suggest that FLAP inhibitors may be therapeutic for RSV-driven eye disease and possibly other inflammatory eye indications.<\/jats:p>","DOI":"10.1128\/cvi.00220-09","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T01:47:04Z","timestamp":1253152024000},"page":"1654-1659","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":13,"title":["A Novel 5-Lipoxygenase-Activating Protein Inhibitor, AM679, Reduces Inflammation in the Respiratory Syncytial Virus-Infected Mouse Eye"],"prefix":"10.1128","volume":"16","author":[{"given":"Alla","family":"Musiyenko","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology (MSB 2370), University of South Alabama, College of Medicine, 307 University Blvd., Mobile, Alabama 36688-0002"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Correa","sequence":"additional","affiliation":[{"name":"Amira Pharmaceuticals, 9535 Waples Street, Ste. 100, San Diego, California 92121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Stock","sequence":"additional","affiliation":[{"name":"Amira Pharmaceuticals, 9535 Waples Street, Ste. 100, San Diego, California 92121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Hutchinson","sequence":"additional","affiliation":[{"name":"Amira Pharmaceuticals, 9535 Waples Street, Ste. 100, San Diego, California 92121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Lorrain","sequence":"additional","affiliation":[{"name":"Amira Pharmaceuticals, 9535 Waples Street, Ste. 100, San Diego, California 92121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen","family":"Bain","sequence":"additional","affiliation":[{"name":"Amira Pharmaceuticals, 9535 Waples Street, Ste. 100, San Diego, California 92121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilly F.","family":"Evans","sequence":"additional","affiliation":[{"name":"Amira Pharmaceuticals, 9535 Waples Street, Ste. 100, San Diego, California 92121"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sailen","family":"Barik","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology (MSB 2370), University of South Alabama, College of Medicine, 307 University Blvd., Mobile, Alabama 36688-0002"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1742-1241.2007.01320.x","volume":"61","year":"2007","unstructured":"Berger, W., M. T. De Chandt, and C. B. Cairns. 2007. Zileuton: clinical implications of 5-lipoxygenase inhibition in severe airway disease. Int. J. Clin. Pract.61:663-676.","journal-title":"Int. J. Clin. Pract."},{"key":"e_1_3_2_3_2","first-page":"369","volume":"27","year":"1985","unstructured":"Bisgaard, H., A. W. Ford-Hutchinson, S. Charleson, and E. Taudorf. 1985. Detection of leukotriene-C4-like immunoreactivity in tear fluid from subjects challenged with specific allergen. Prostaglandins27:369-374.","journal-title":"Prostaglandins"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01437-06"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm1164","volume":"11","year":"2005","unstructured":"Bitko, V., A. Musiyenko, O. Shulyayeva, and S. Barik. 2005. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med.11:50-55.","journal-title":"Nat. Med."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2180-4-28","volume":"4","year":"2004","unstructured":"Bitko, V., N. E. Garmon, T. Cao, B. Estrada, J. E. Oakes, R. N. Lausch, and S. Barik. 2004. Activation of cytokines and NF-kappa B in corneal epithelial cells infected by respiratory syncytial virus: potential relevance in ocular inflammation and respiratory infection. BMC Microbiol.4:28-38.","journal-title":"BMC Microbiol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/14787210.3.5.719","volume":"3","year":"2005","unstructured":"Cardenas, S. A., A. Auais, and G. Piedimonte. 2005. Palivizumab in the prophylaxis of respiratory syncytial virus infection. Expert Rev. Anti Infect. Ther.3:719-726.","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","volume":"25","year":"2006","unstructured":"Ciana, P., M. Fumagalli, M. L. Trincavelli, C. Verderio, P. Rosa, D. Lecca, S. Ferrario, C. Parravicini, V. Capra, P. Gelosa, U. Guerrini, S. Belcredito, M. Cimino, L. Sironi, E. Tremoli, G. E. Rovati, C. Martini, and M. P. Abbracchio. 2006. The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor. EMBO J.25:4615-4627.","journal-title":"EMBO J."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01625-07"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0952-3278(03)00072-3","volume":"69","year":"2003","unstructured":"Evans, J. F. 2003. The cysteinyl leukotriene receptors. Prostaglandins Leukot. Essent. Fatty Acids69:117-122.","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tips.2007.11.006","volume":"29","year":"2008","unstructured":"Evans, J. F., A. D. Ferguson, R. T. Moseley, and J. H. Hutchinson. 2008. What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases. Trends Pharmacol. Sci.29:72-78.","journal-title":"Trends Pharmacol. Sci."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.all.0000200506.62048.06","volume":"6","year":"2006","unstructured":"Everard, M. L. 2006. The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children. Curr. Opin. Allergy Clin. Immunol.6:56-61.","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","volume":"352","year":"2005","unstructured":"Falsey, A. R., P. A. Hennessey, M. A. Formica, C. Cox, and E. E. Walsh. 2005. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med.352:1749-1759.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/thx.2008.102111","volume":"64","year":"2009","unstructured":"Forton, J. T., K. Rowlands, K. Rockett, N. Hanchard, M. Herbert, D. P. Kwiatkowski, and J. Hull. 2009. Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster. Thorax64:345-352.","journal-title":"Thorax"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1080\/02713689808951239","volume":"17","year":"1998","unstructured":"Fujishima, H., I. Saito, Y. Okamnato, T. Takeuchi, and K. Tsubota. 1998. Respiratory syncytial virus-induced interleukin-4 production by human conjunctival epithelial cells contributes to allergy: preliminary study. Curr. Eye Res.17:656-662.","journal-title":"Curr. Eye Res."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1399-3038.2005.00248.x","volume":"16","year":"2005","unstructured":"Fullmer, J. J., A. M. Khan, O. Elidemir, C. Chiapetta, J. M. Stark, and G. N. Colasurdo. 2005. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB\/c mice. Pediatr. Allergy Immunol.16:593-601.","journal-title":"Pediatr. Allergy Immunol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1001\/jama.1986.03380190076028","volume":"256","year":"1986","unstructured":"Gala, C. L., C. B. Hall, K. C. Schnabel, P. H. Pincus, P. Blossom, S. W. Hildreth, R. F. Betts, and R. G. Douglas, Jr. 1986. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA256:2706-2708.","journal-title":"JAMA"},{"key":"e_1_3_2_18_2","first-page":"119","volume":"29","year":"1988","unstructured":"Gary, R. K., D. F. Woodward, A. L. Nieves, L. S. Williams, J. G. Gleason, and M. A. Wasserman. 1988. Characterization of the conjunctival vasopermeability response to leukotrienes and their involvement in immediate hypersensitivity. Investig. Ophthalmol. Vis. Sci.29:119-126.","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.iy.11.040193.002155","volume":"11","year":"1993","unstructured":"Germain, R. N. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol.11:403-405.","journal-title":"Annu. Rev. Immunol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1167\/iovs.02-0656","volume":"44","year":"2003","unstructured":"Girgis, D. O., G. D. Sloop, J. M. Reed, and R. J. O'Callaghan. 2003. A new topical model of Staphylococcus corneal infection in the mouse. Investig. Ophthalmol. Vis. Sci.44:1591-1597.","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaci.2006.03.040","volume":"118","year":"2006","unstructured":"Gyllfors, P., S. E. Dahlen, M. Kumlin, K. Larsson, and B. Dahlen. 2006. Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticazone propionate. J. Allergy Clin. Immunol.118:78-83.","journal-title":"J. Allergy Clin. Immunol."},{"key":"e_1_3_2_22_2","unstructured":"J. Med. Chem."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1076\/ocii.7.1.35.8107","volume":"7","year":"1999","unstructured":"Irkec, M. T., M. Orhan, and U. Erdener. 1999. Role of tear inflammatory mediators in contact lens-associated giant papillary conjunctivitis in soft contact lens wearers. Ocul. Immunol. Inflamm.7:35-38.","journal-title":"Ocul. Immunol. Inflamm."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/pupt.1999.0188","volume":"12","year":"1999","unstructured":"Jones, T. R., and I. W. Rodger. 1999. Role of leukotrienes and leukotriene receptor antagonists in asthma. Pulm. Pharmacol. Ther.12:107-110.","journal-title":"Pulm. Pharmacol. Ther."},{"key":"e_1_3_2_25_2","first-page":"3679","volume":"34","year":"1993","unstructured":"Krauss, H.-P., and D. F. Woodward. 1993. Polymorphonuclear leukocyte infiltration into the subretinal choroid and optic nerve in response to leukotrienes. Investig. Ophthalmol. Vis. Sci.34:3679-3686.","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"16695","DOI":"10.1073\/pnas.0808993105","volume":"105","year":"2008","unstructured":"Maekawa, A., Y. Kanaoka, X. Xing, and K. F. Austen. 2008. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl 1 and 2 receptors. Proc. Natl. Acad. Sci. USA105:16695-16700.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2332\/allergolint.O-06-476","volume":"56","year":"2007","unstructured":"Matsuse, H., H. Hirose, T. Tsuchida, S. Fukahori, C. Fukushima, Y. Mizuta, and S. Kohno. 2007. Effects of respiratory syncytial virus infection on dendritic cells and cysteinyl leukotrienes in lung tissues of a murine model of asthma. Allergol. Int.56:165-169.","journal-title":"Allergol. Int."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00671-08"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbrc.2005.09.052","volume":"337","year":"2005","unstructured":"Nonaka, Y., T. Hiramoto, and N. Fujita. 2005. Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods. Biochem. Biophys. Res. Commun.337:281-288.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"e_1_3_2_30_2","first-page":"CD004878","volume":"3","year":"2004","unstructured":"Patel, H., R. Platt, J. M. Lozano, and E. E. Wang. 2004. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst. Rev.3:CD004878.","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"11356","DOI":"10.1074\/jbc.271.19.11356","volume":"271","year":"1996","unstructured":"Penrose, J. F., J. Spector, M. Baldasaro, K. Xu, J. Boyce, J. P. Arm, K. F. Austen, and B. K. Lam. 1996. Cloning of the gene for human leukotriene C4 synthase. Organization, nucleotide sequence and chromosomal localization to 5q35. J. Biol. Chem.271:11356-11361.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ppul.20285","volume":"40","year":"2005","unstructured":"Piedimonte, G., G. Renzetti, A. Auais, A. Di Marco, S. Tripodi, F. Colistro, A. Villani, V. Di Ciommo, and R. Cutrera. 2005. Leukotriene synthesis during respiratory syncytial virus bronchiolitis: influence of age and atopy. Pediatr. Pulmonol.40:285-291.","journal-title":"Pediatr. Pulmonol."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2180-6-26","volume":"6","year":"2006","unstructured":"Urnowey, S., T. Ansai, V. Bitko, K. Nakayama, T. Takehara, and S. Barik. 2006. Temporal activation of anti- and pro-apoptotic factors in human gingival fibroblasts infected with the periodontal pathogen, Porphyromonas gingivalis: a potential role of bacterial proteases in host signaling. BMC Microbiol.6:26.","journal-title":"BMC Microbiol."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0223-5234(99)00225-1","volume":"34","year":"1999","unstructured":"Young, R. N. 1999. Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be fully realized? Eur. J. Chem.34:671-685.","journal-title":"Eur. J. Chem."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00220-09","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00220-09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:41:34Z","timestamp":1627591294000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00220-09"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1128\/CVI.00220-09"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00220-09","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"2009-05-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-09-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}